Azrin, Linda B.

Your profile? Update now
Updated 05/18/09

firm image

Jones Day

222 East 41st Street

New York, NY 10017-6702

Phone: 1.212.326.3894 (Business Phone)

Fax: 1.212.755.7306 (Business Fax)

Contact Us (Business Email)

Websites associated with this firm:http://www.jonesday.com

Summary

Current Employment Position(s)

Associate

Lawyer Overview

Linda Azrin's practice includes patent prosecution of U.S., PCT, and foreign applications; preparation of patentability, infringement, validity, and freedom-to-operate opinions; and assistance with litigations and due diligence investigations. Linda has experience with various chemical and mechanical technologies, including medical devices, consumer products, and chemical compositions.

Prior to joining Jones Day, Linda was an associate at the intellectual property firm of Pennie & Edmonds LLP from 1999 to 2003. Before law school, Linda was a chemist at Dupont (NEN Medical Research Products) for four years where she synthesized radio-labeled biochemical compounds used for medical research.

She is a member of the New York Intellectual Property Law Association and the American Bar Association.

Areas of Practice

  • Intellectual Property
  • Patent Prosecution
  • Life Sciences
  • Medical Devices

Representative Cases

  • Martek Biosciences Corp. v. Nutrinova Inc., No. Civ.A.03-896 (D. Del. filed Sept. 23, 2003)

West Practice Categories

Copyrights, Intellectual Property Law, International Intellectual Property, Patents, Technology Licensing, Trade Dress, Trade Secrets, Trademarks

Qualifications

Bar Admissions

  • New York, First Department

Education

  • Illinois Institute of Tech

Office Information

Address

222 East 41st Street
New York, NY 10017-6702

Phones

1.212.326.3894 (Business Phone)

Faxes

1.212.755.7306 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.jonesday.com

When viewing a listing, consider the state advertising restrictions to which lawyers and law firms must adhere, as well as our West Legal Directory disclaimers.